miR-200 family expression results in highly proliferative ovarian cancer cells. Yet this expression is also linked to longer overall survival in women with ovarian cancer. A new study sheds light into this apparent paradox showing that two members of this family—miR-141 and miR-200a—not only boost tumor growth but also sensitize tumor cells to chemotherapy (pages 1627–1635).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
Scientific Reports Open Access 07 October 2020
-
miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas
Scientific Reports Open Access 15 June 2017
-
Cancer-derived immunoglobulin G promotes tumor cell growth and proliferation through inducing production of reactive oxygen species
Cell Death & Disease Open Access 05 December 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

Marina Corral
References
Iliopoulos, D. et al. Mol. Cell 39, 761–772 (2010).
Gregory, P.A. et al. Nat. Cell Biol. 10, 593–601 (2008).
Iorio, M.V. et al. Cancer Res. 67, 8699–8707 (2007).
van Jaarsveld, M.T. et al. Int. J. Biochem. Cell Biol. 42, 1282–1290 (2010).
Matsuzawa, A. & Ichijo, H. Biochim. Biophys. Acta 1780, 1325–1336 (2008).
Nguyen, T., Nioi, P. & Pickett, C.B. J. Biol. Chem. 284, 13291–13295 (2009).
Dolado, I. et al. Cancer Cell 11, 191–205 (2007).
Mateescu, B. et al. Nat. Med. 17, 1627–1635 (2011).
Issbrücker, K. et al. FASEB J. 17, 262–264 (2003).
Hu, X. et al. Gynecol. Oncol. 114, 457–464 (2009).
Marchini, S. et al. Lancet Oncol. 12, 273–285 (2011).
Cochrane, D.R. et al. J. Oncol. 2010, 821717 (2010).
Leskelä, S. et al. Endocr. Relat. Cancer 18, 85–95 (2011).
Alexandre, J. et al. Cancer Res. 67, 3512–3517 (2007).
Cho, J.M. et al. Cancer Lett. 260, 96–108 (2008).
Helleman, J. et al. Gynecol. Oncol. 117, 170–176 (2010).
Konstantinopoulos, P.A. et al. Cancer Res. 71, 5081–5089 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Wiemer, E. Stressed tumor cell, chemosensitized cancer. Nat Med 17, 1552–1554 (2011). https://doi.org/10.1038/nm.2593
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2593
This article is cited by
-
miR-22 suppresses cell viability and EMT of ovarian cancer cells via NLRP3 and inhibits PI3K/AKT signaling pathway
Clinical and Translational Oncology (2021)
-
Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
Scientific Reports (2020)
-
miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas
Scientific Reports (2017)
-
Cancer-derived immunoglobulin G promotes tumor cell growth and proliferation through inducing production of reactive oxygen species
Cell Death & Disease (2013)